Novo Nordisk strikes second licensing deal since frosty capital-markets day
- Novo Nordisk 近 90 天出现 15 次
- 上一次：3 天前 · Novo Nordisk signed a $1.3 billion deal for technology to make longer-lasting obesity shots
发生了什么
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
摘要按规则整理自下方来源原文